多模态机器学习预测精神病高危与近期抑郁患者的精神病发作
本研究在7个欧洲学术早期识别服务中心随访167名临床高危综合征患者和167名近期起病抑郁患者,评估多模态机器学习整合临床、神经认知、结构MRI和多基因风险评分预测精神病发作的效能。结果显示算法敏感度高但特异度低,临床医生特异度高但敏感度低;整合算法与医生判断的流程平衡准确度达85.5%-85.9%,且外部验证结果良好。
要点
- 多模态机器学习可预测临床高危和近期起病抑郁患者的精神病发作。
- 算法敏感度高但特异度低,临床医生特异度高但敏感度低。
- 序贯整合算法与医生判断的流程平衡准确度达85.5%-85.9%。
核心结论
- 序贯整合算法与临床医生的风险评估可在更宽的风险谱中预测精神病发作。
- 所提出的流程需经大规模国际验证后方可临床转化。
研究设计与样本
- 多中心纵向预后研究,在5个欧洲国家的7个学术早期识别服务中心进行。
- 纳入167例临床高危综合征患者和167例近期起病抑郁患者,另设334名健康志愿者作为常模样本。
- 246例完成18个月随访者用于模型训练和留一站点交叉验证,88例未转化者用于模型特异度验证。
- 3个独立瑞士项目提供45例转化和600例未转化病例用于外部验证。
主要发现
- 26例(23例临床高危综合征和3例近期起病抑郁)发展为精神病。
- 临床医生平衡准确度73.2%,特异度84.9%,敏感度61.5%。
- 算法敏感度76.0%-88.0%,特异度53.5%-66.8%。
- 整合所有算法与人工组件的控制论风险计算器平衡准确度85.5%(敏感度84.6%,特异度86.4%)。
- 最优预后流程平衡准确度85.9%(敏感度84.6%,特异度87.3%),诊断负担更低。
关键数值与推荐
- 临床医生平衡准确度73.2%(特异度84.9%,敏感度61.5%)。
- 算法敏感度76.0%-88.0%,特异度53.5%-66.8%。
- 控制论风险计算器平衡准确度85.5%(敏感度84.6%,特异度86.4%)。
- 最优预后流程平衡准确度85.9%(敏感度84.6%,特异度87.3%)。
临床怎么用
- 可序贯整合临床-神经认知、专家判断、多基因风险评分和结构MRI风险估计以预测精神病发作。
- 该流程在临床转化前需进行大规模国际验证。
局限性
- 转化事件数较少(26例),可能影响模型稳定性。
- 需大规模国际验证后方可临床转化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Diverse models have been developed to predict psychosis in patients with clinical high-risk (CHR) states. Whether prediction can be improved by efficiently combining clinical and biological models and by broadening the risk spectrum to young patients with depressive syndromes remains unclear. OBJECTIVES: To evaluate whether psychosis transition can be predicted in patients with CHR or recent-onset depression (ROD) using multimodal machine learning that optimally integrates clinical and neurocognitive data, structural magnetic resonance imaging (sMRI), and polygenic risk scores (PRS) for schizophrenia; to assess models' geographic generalizability; to test and integrate clinicians' predictions; and to maximize clinical utility by building a sequential prognostic system. DESIGN, SETTING, AND PARTICIPANTS: This multisite, longitudinal prognostic study performed in 7 academic early recognition services in 5 European countries followed up patients with CHR syndromes or ROD and healthy volunteers. The referred sample of 167 patients with CHR syndromes and 167 with ROD was recruited from February 1, 2014, to May 31, 2017, of whom 26 (23 with CHR syndromes and 3 with ROD) developed psychosis. Patients with 18-month follow-up (n = 246) were used for model training and leave-one-site-out cross-validation. The remaining 88 patients with nontransition served as the validation of model specificity. Three hundred thirty-four healthy volunteers provided a normative sample for prognostic signature evaluation. Three independent Swiss projects contributed a further 45 cases with psychosis transition and 600 with nontransition for the external validation of clinical-neurocognitive, sMRI-based, and combined models. Data were analyzed from January 1, 2019, to March 31, 2020. MAIN OUTCOMES AND MEASURES: Accuracy and generalizability of prognostic systems. RESULTS: A total of 668 individuals (334 patients and 334 controls) were included in the analysis (mean [SD] age, 25.1 [5.8] years; 354 [53.0%] female and 314 [47.0%] male). Clinicians attained a balanced accuracy of 73.2% by effectively ruling out (specificity, 84.9%) but ineffectively ruling in (sensitivity, 61.5%) psychosis transition. In contrast, algorithms showed high sensitivity (76.0%-88.0%) but low specificity (53.5%-66.8%). A cybernetic risk calculator combining all algorithmic and human components predicted psychosis with a balanced accuracy of 85.5% (sensitivity, 84.6%; specificity, 86.4%). In comparison, an optimal prognostic workflow produced a balanced accuracy of 85.9% (sensitivity, 84.6%; specificity, 87.3%) at a much lower diagnostic burden by sequentially integrating clinical-neurocognitive, expert-based, PRS-based, and sMRI-based risk estimates as needed for the given patient. Findings were supported by good external validation results. CONCLUSIONS AND RELEVANCE: These findings suggest that psychosis transition can be predicted in a broader risk spectrum by sequentially integrating algorithms' and clinicians' risk estimates. For clinical translation, the proposed workflow should undergo large-scale international validation.
引用
- Koutsouleris N, Dwyer DB, Degenhardt F, et al. Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression. JAMA Psychiatry. 2021. PMID: 33263726. doi:10.1001/jamapsychiatry.2020.3604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。